VERI vs GFAI vs BBAI vs PRCT

For growth investors, PROCEPT BioRobotics Corporation (PRCT) is the stronger pick with 37.

2% revenue growth year-over-year, versus -19. 3% for BigBear. ai Holdings, Inc. (BBAI). Analysts rate Veritone, Inc. (VERI) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, PROCEPT BioRobotics Corporation (PRCT) delivered a total return of -39.

3%, compared to -99. 5% for Guardforce AI Co. , Limited (GFAI). Over 10 years, the gap is even starker: PRCT returned -39. 3% versus GFAI's -99. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), PROCEPT BioRobotics Corporation (PRCT) is the lower-risk stock at 1.

23β versus Veritone, Inc. 's 3. 34β — meaning VERI is approximately 170% more volatile than PRCT relative to the S&P 500. On balance sheet safety, BigBear. ai Holdings, Inc. (BBAI) carries a lower debt/equity ratio of 4% versus 9% for Veritone, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), PROCEPT BioRobotics Corporation (PRCT) is pulling ahead at 37.

2% versus -19. 3% for BigBear. ai Holdings, Inc. (BBAI). On earnings-per-share growth, the picture is similar: Guardforce AI Co. , Limited grew EPS 88. 3% year-over-year, compared to 1. 7% for PROCEPT BioRobotics Corporation. Over a 3-year CAGR, PRCT leads at 60. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Guardforce AI Co.

, Limited (GFAI) is the more profitable company, earning -16. 1% net margin versus -230. 2% for BigBear. ai Holdings, Inc. — meaning it keeps -16. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GFAI leads at -18. 5% versus -95. 2% for VERI. At the gross margin level — before operating expenses — VERI leads at 70. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, PROCEPT BioRobotics Corporation (PRCT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

23)). Guardforce AI Co. , Limited (GFAI) carries a higher beta of 2. 31 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PRCT: -39. 3%, GFAI: -99. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (VERI (Technology) and GFAI (Industrials) and BBAI (Technology) and PRCT (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: VERI is a small-cap quality compounder stock; GFAI is a small-cap quality compounder stock; BBAI is a mid-cap quality compounder stock; PRCT is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.